全文获取类型
收费全文 | 1958篇 |
免费 | 101篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 66篇 |
妇产科学 | 46篇 |
基础医学 | 332篇 |
口腔科学 | 35篇 |
临床医学 | 125篇 |
内科学 | 309篇 |
皮肤病学 | 55篇 |
神经病学 | 154篇 |
特种医学 | 47篇 |
外科学 | 292篇 |
综合类 | 12篇 |
预防医学 | 235篇 |
眼科学 | 40篇 |
药学 | 188篇 |
中国医学 | 2篇 |
肿瘤学 | 119篇 |
出版年
2021年 | 41篇 |
2020年 | 27篇 |
2019年 | 38篇 |
2018年 | 42篇 |
2017年 | 31篇 |
2016年 | 27篇 |
2015年 | 36篇 |
2014年 | 61篇 |
2013年 | 52篇 |
2012年 | 103篇 |
2011年 | 113篇 |
2010年 | 62篇 |
2009年 | 46篇 |
2008年 | 84篇 |
2007年 | 75篇 |
2006年 | 76篇 |
2005年 | 83篇 |
2004年 | 82篇 |
2003年 | 72篇 |
2002年 | 81篇 |
2001年 | 65篇 |
2000年 | 49篇 |
1999年 | 41篇 |
1998年 | 15篇 |
1997年 | 14篇 |
1996年 | 17篇 |
1995年 | 18篇 |
1993年 | 13篇 |
1992年 | 31篇 |
1991年 | 28篇 |
1990年 | 26篇 |
1989年 | 27篇 |
1988年 | 23篇 |
1987年 | 21篇 |
1986年 | 25篇 |
1985年 | 22篇 |
1984年 | 18篇 |
1983年 | 19篇 |
1979年 | 24篇 |
1978年 | 16篇 |
1976年 | 13篇 |
1975年 | 17篇 |
1974年 | 15篇 |
1973年 | 20篇 |
1972年 | 15篇 |
1971年 | 22篇 |
1970年 | 22篇 |
1969年 | 24篇 |
1968年 | 21篇 |
1967年 | 24篇 |
排序方式: 共有2070条查询结果,搜索用时 109 毫秒
1.
Rolf Svedjeholm Gabriele Ferrari Farkas Vanky Örjan Friberg Jonas Holm 《Acta anaesthesiologica Scandinavica》2023,67(10):1373-1382
Background
Glutamate plays a key role for post-ischaemic recovery of myocardial metabolism. According to post hoc analyses of the two GLUTAMICS trials, patients without diabetes benefit from glutamate with less myocardial dysfunction after coronary artery bypass surgery (CABG). Copeptin reflects activation of the Arginine Vasopressin system and is a reliable marker of heart failure but available studies in cardiac surgery are limited. We investigated whether glutamate infusion is associated with reduced postoperative rises of plasma Copeptin (p-Copeptin) after CABG.Methods
A prespecified randomised double-blind substudy of GLUTAMICS II. Patients had left ventricular ejection fraction ≤0.30 or EuroSCORE II ≥3.0 and underwent CABG ± valve procedure. Intravenous infusion of 0.125 M L-glutamic acid or saline at 1.65 mL/kg/h was commenced 10–20 min before the release of the aortic cross-clamp and then continued for another 150 min P-Copeptin was measured preoperatively and postoperatively on day one (POD1) and day three. The primary endpoint was an increase in p-Copeptin from the preoperative level to POD1. Postoperative stroke ≤24 h and mortality ≤30 days were safety outcomes.Results
We included 181 patients of whom 48% had diabetes. The incidence of postoperative mortality ≤30 days (0% vs. 2.1%; p = .50) and stroke ≤24 h (0% vs. 3.2%; p = .25) did not differ between the glutamate group and controls. P-Copeptin increased postoperatively with the highest values recorded on POD1 without significant inter-group differences. Among patients without diabetes, p-Copeptin did not differ preoperatively but postoperative rise from preoperative level to POD1 was significantly reduced in the glutamate group (73 ± 66 vs. 115 ± 102 pmol/L; p = .02). P-Copeptin was significantly lower in the Glutamate group on POD1 (p = .02) and POD 3 (p = .02).Conclusions
Glutamate did not reduce rises of p-Copeptin significantly after moderate to high-risk CABG. However, glutamate was associated with reduced rises of p-Copeptin among patients without diabetes. These results agree with previous observations suggesting that glutamate mitigates myocardial dysfunction after CABG in patients without diabetes. Given the exploratory nature of these findings, they need to be confirmed in future studies. 相似文献2.
3.
Paul Overdorf Jr. Gary J. Farkas Natasha Romanoski 《The journal of spinal cord medicine》2020,43(3):398-401
Context: Autonomic dysreflexia and dysautonomia can be a common complication following spinal cord injury, especially at levels of T6 and above and can lead to complications associated with the pupil. In this case report, we review autonomic dysreflexia, the anatomy and physiology of the sympathetic nervous system of the eye, as well as review the clinical relevance in understanding autonomic and pupillary changes in response to autonomic dysfunction.Findings: We present a patient with an incomplete C4 level injury who was found to have isolated anisocoria on two separate occasions during his acute inpatient rehabilitation stay.Conclusion/Clinical Relevance: Anisocoria associated with abnormal sympathetic activation may be a clinical sign of dysautonomia. 相似文献
4.
5.
6.
γEpithelial Na+ Channel (γENaC) and the Acid‐Sensing Ion Channel 1 (ASIC1) expression in the urothelium of patients with neurogenic detrusor overactivity 下载免费PDF全文
7.
8.
Mehmet Ali Altay DDS PhD Alexandra Radu DMD Sean E. Pack DDS MD Nelli Yıldırımyan DDS Andres Flores-Hidalgo DDS Dale A. Baur DDS MD 《Cranio : the journal of craniomandibular practice》2020,38(5):333-341
ABSTRACT
Objectives
This study aimed to evaluate and report the outcomes associated with the management of patients who were treated surgically for medication-related osteonecrosis of the jaw (MRONJ).Methods: Demographic and medical profiles of patients with a diagnosis of MRONJ were created. The type of surgical treatment, complications, and treatment outcomes were identified.Results: Twenty-one patients with an average age of 68.42 years (range 40–90 years) were included. Nineteen patients had only mandible involvement, one patient had only maxilla involvement, and one patient had both mandible and maxilla involvement. Thirteen patients underwent marginal resections. Eight patients underwent segmental resection of the mandible with immediate reconstruction. Nineteen patients healed without any complications. Two patients who had undergone segmental resection of the mandible experienced postoperative complications and needed a second surgery to achieve primary closure.Discussion: Advanced MRONJ can effectively be treated with resective surgery in combination with medical treatment. 相似文献9.
Pratt VM Zehnbauer B Wilson JA Baak R Babic N Bettinotti M Buller A Butz K Campbell M Civalier C El-Badry A Farkas DH Lyon E Mandal S McKinney J Muralidharan K Noll L Sander T Shabbeer J Smith C Telatar M Toji L Vairavan A Vance C Weck KE Wu AH Yeo KT Zeller M Kalman L 《The Journal of molecular diagnostics : JMD》2010,12(6):835-846
Pharmacogenetic testing is becoming more common; however, very few quality control and other reference materials that cover alleles commonly included in such assays are currently available. To address these needs, the Centers for Disease Control and Prevention's Genetic Testing Reference Material Coordination Program, in collaboration with members of the pharmacogenetic testing community and the Coriell Cell Repositories, have characterized a panel of 107 genomic DNA reference materials for five loci (CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1) that are commonly included in pharmacogenetic testing panels and proficiency testing surveys. Genomic DNA from publicly available cell lines was sent to volunteer laboratories for genotyping. Each sample was tested in three to six laboratories using a variety of commercially available or laboratory-developed platforms. The results were consistent among laboratories, with differences in allele assignments largely related to the manufacturer's assay design and variable nomenclature, especially for CYP2D6. The alleles included in the assay platforms varied, but most were identified in the set of 107 DNA samples. Nine additional pharmacogenetic loci (CYP4F2, EPHX1, ABCB1, HLAB, KIF6, CYP3A4, CYP3A5, TPMT, and DPD) were also tested. These samples are publicly available from Coriell and will be useful for quality assurance, proficiency testing, test development, and research. 相似文献
10.